Adjuvant arthritis (AA) These data demonstrate a disruption of the normal mechanisms underlying feedback inhibition of the HPA axis by glucocorticoids during AA. Similarly, the glucocorticoid-dependent regulation of GH and prolactin mRNA expression is altered in AA.
INTRODUCTION
Certain strains of rat develop a chronic inflammatory arthritis (adjuvant arthritis, AA) after intradermal injection of mycobacterial adjuvant into the base of the tail (Pearson, 1956; Pearson & Wood, 1959; Waksman et al. 1960 ). AA is a T lymphocytedependent (Taurog et al. 1983; Holoshitz et al. 1984 ; Van Eden et al. 1985) , strain-specific (Colpaert, 1988) , immunologically mediated disease, which is associated with a number of neuroendocrine changes (Neidhart & Larson, 1990) .
We have previously shown that the development of AA is accompanied by chronic activation of the hypothalamic-pituitary-adrenal (HPA) axis, with increased morning adrenocorticotrophic hormone (ACTH) and corticosterone levels, together with abolition of the normal diurnal rhythms of ACTH and corticosterone . Anterior pitu¬ itary pro-opiomelanocortin (POMC) mRNA levels are also increased during the development of AA ). Thus, in this model of chronic inflammatory stress, the drive to ACTH secretion is increased, despite the chronic increase in corticosterone secretion. Recent studies have, however, shown that the hypothalamic expression of corticotrophin-releasing hormone (CRH) mRNA and CRHM1 peptide levels in the hypophyseal portal venous blood are not increased in animals with AA (Harbuz et al. 1992a) , suggesting that the primary drive to the HPA axis is not hypothalamic CRH (Harbuz et al. 19926) . Plasma levels of both growth hormone (GH) and prolactin are also affected by the development of AA. Prolactin secretion increases early on and then drops sharply prior to the clinical manifestations of the disease, while GH levels have been shown to be reduced (Neidhart & Larson, 1990) .
The inhibitory effects of pharmacological doses of glucocorticoids on normal growth patterns have been documented both in experimental animals (Evans et al. 1943 ) and in humans (Blodgett et al. 1956 ). Patients with hypercortisolaemia due to Cushing's disease or long-term glucocorticoid ther¬ apy have reduced GH secretion (Krieger & Glick, 1972) . In contrast, recent reports suggest that gluco¬ corticoids may have permissive effects on stimulated GH release, depending on the duration of pituitary exposure to the steroids (Casanueva et al. 1988 (Casanueva et al. , 1990 . In-vitro studies have demonstrated a stimula¬ tory effect of dexamethasone on GH secretion and GH mRNA accumulation in somatotrophs (Levy & Lightman, 1988) . Both CRH and ACTH have also been reported to increase GH secretion during the day, although not at night, suggesting that the level of activity of the HPA axis may play a role in deter¬ mining GH secretion patterns (Wiederman et al. 1991) . The prolactin response, however, is quite different, and glucocorticoids have been shown to have an inhibitory effect on both prolactin secre¬ tion (Kiem et al. 1990 ) and mRNA expression (Somasekhar & Gorski, 1988 (Zar, 1984) .
RESULTS

ACTH in ADX/AA animals
In ADX/AA animals on days 7 and 14 after adjuvant injection, circulating ACTH levels were not signifi¬ cantly different from those observed in ADX animals ( Fig. 1 (Fig.  4) . The semiquantitative analysis of these results is shown in Fig. 5 (Fig. 4) . The semiquantitative analysis of these results is shown in Fig. 5 .
Anterior pituitary prolactin mRNA in ADX/ AA animals
In the C20, C40 and C80 animals, increasing cortico¬ sterone pellet dose resulted in slightly reduced pro¬ lactin mRNA accumulation by day 7. In the AA20, AA40 and AA80 animals, a further decrease in pro¬ lactin mRNA accumulation was also observed dur¬ ing the development of AA. These effects were unaffected by the dose of the corticosterone pellets (Fig. 4) . The semiquantitative analysis of these results is shown in Fig. 5 (Fig. 6 ).
In the AA20, AA40 and AA80 animals on day 14 after injection, the volume of the inflamed paws was reduced by the administration of corticosterone pel¬ lets in a dose-dependent manner, the paw volume being inversely correlated with plasma corticos¬ terone levels (Fig. 7) . DISCUSSION We have previously shown that in intact AA animals, pituitary POMC mRNA and circulating ACTH and corticosterone levels are all increased, with loss of the normal diurnal rhythm of plasma ACTH and corticosterone Stephanou et al. 1992) . Both acute and chronic non-inflammatory stresses result in an increase in the secretion of ACTH from the pituitary (Henkin 65c Knigge, 1963; Mikulaj & Mitro, 1972; Cook et al. 1973; Reigle, 1973; Ruhmann-Wennhold & Nelson, 1977) and consequent secretion of corticosterone from the adrenals, which in turn has feedback effects in reduc¬ ing ACTH secretion from the pituitary (Bohus, 1969; Dallman & Yates, 1969; Keller-Wood & Dallman, 1984 ).
In AA animals, in addition to the stimulation of the HPA axis, there is also activation of the immune system (Connoly et al. 1988; Whitehouse, 1988; Leisten et al. 1990) . We factor-a and IL-6 plasma levels are also increased in AA animals (Shinmei et al. 1989) , and these cytokines have been shown to act at both the hypothalamic and pituitary level to activate the HPA axis (Brown et al. 1987; Evans, 1989; Navarra et al. 1990; Snick, 1990; Suda et al. 1990 ). IL-lß and IL-6 administered intravenously can also cause increased release of ACTH and corticosterone into the periph¬ eral circulation (Harbuz et al. 1992c (Casanueva et al. 1988 (Casanueva et al. , 1990 Wiederman et al. 1991 
